tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
FibroGen (FGEN)
NASDAQ:FGEN
US Market
FGEN
FibroGen
RESEARCH TOOLSreports
Advertisement

FibroGen (FGEN) Stock News & Sentiment

Compare
1,069 Followers
FibroGen’s Strategic and Financial Advancements: A Positive Outlook on FG-3246 and Roxadustat
Premium
Ratings
FibroGen’s Strategic and Financial Advancements: A Positive Outlook on FG-3246 and Roxadustat
30d ago
FGEN
FibroGen Sells Subsidiary to AstraZeneca for $220 Million
Premium
Company Announcements
FibroGen Sells Subsidiary to AstraZeneca for $220 Million
2M ago
8K
FGEN
FibroGen’s Strategic Moves and Clinical Prospects Drive Buy Rating
Premium
Ratings
FibroGen’s Strategic Moves and Clinical Prospects Drive Buy Rating
2M ago
FGEN
FibroGen Sells Subsidiary to AstraZeneca for $220M
Premium
Company Announcements
FibroGen Sells Subsidiary to AstraZeneca for $220M
2M ago
8K
FGEN
FibroGen’s Earnings Call Highlights Strategic Advances and Financial Challenges
Premium
Company Announcements
FibroGen’s Earnings Call Highlights Strategic Advances and Financial Challenges
2M ago
FGEN
FibroGen Gains Approval for Subsidiary Sale to AstraZeneca
Premium
Company Announcements
FibroGen Gains Approval for Subsidiary Sale to AstraZeneca
2M ago
8K
FGEN
FibroGen Amends Financing Agreement with Morgan Stanley
Premium
Company Announcements
FibroGen Amends Financing Agreement with Morgan Stanley
2M ago
8K
FGEN
More FGEN News >

FGEN News on the Web

William Blair Remains a Hold on FibroGen (FGEN)
TipRanks News
Neutral
FibroGen (FGEN) Reports Q2 Loss, Lags Revenue Estimates
Zacks
Neutral
FibroGen price target adjusted to $43 at H.C. Wainwright after reverse split
The Fly
Neutral
Stock Market Today: PROK Soars 515% on Surging Volume Amid Clinical Trial Buzz
The Motley Fool
Neutral
Upcoming Stock Splits This Week (June 16 to June 20) – Stay Invested
TipRanks News
Neutral
FibroGen Announces Reverse Stock Split Effective June 16
TipRanks News
Neutral
FibroGen Inc. Q1 Earnings Summary
rttnews
Neutral
FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates
Zacks
Bearish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FGEN’s Media Buzz Sentiment?
Currently, no data Available
What is FGEN’s weekly average amount of articles?
Currently, no data Available
What is FGEN’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
ALKSAlkermes
VSTMVerastem
NNVCNanoViricides
CSTLCastle Biosciences
S5YASigma Healthcare Ltd
Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis
Subscribe NowSee Plans & Pricing